Renalogic News

Renalogic and MZQ Consulting to Partner For the Benefit of Group Health Plans: Category Leaders Collaborate to Extend Market Leading Compliance and Cost Containment Solutions

Media Release

CHICAGO, IL and BALTIMORE, MD ­– July 17, 2023 – Renalogic, the leading company helping employers and self-funded health plans fight the human and financial costs of chronic kidney disease (CKD) and end-stage renal disease (ESRD), and MZQ Consulting, the leading compliance and reporting service for self-funded plans, announced today their collaboration to benefit group health plans, benefit advisors and third-party administrators.

“As ERISA-governed group health plans and their advisors and partners continue to face growing compliance regulations and increased scrutiny of fiduciary responsibilities and transparency, it is ever more important that they have a true expert in their corner, guiding them and facilitating requisite reporting,” said Kevin Weinstein, CEO of Renalogic. “Our clients and partners will benefit greatly from MZQ’s expertise, and we are thrilled to be able to recommend their services as a recognized Partner.”

“Renalogic has been at the forefront of fighting CKD and ESRD on behalf of group plans and their members for more than 20 years,” said MZQ Consulting CEO Jennifer Berman. “Many of the plans we work with can benefit from their expertise and leadership, and we are very excited to help facilitate such conversations.”

MZQ, a concierge compliance firm that excels at making the complex simple, has been at the forefront of ERISA compliance services since the passage of the Affordable Care Act in 2010. Today, the company offers complete services, including ACA compliance, ACA tracking, Employer Mandate Penalty Resolution, Form 5500 Preparation, Non-Discrimination Testing, and Mental Health Parity Analysis. Their industry-leading MZQ Compass Plan creates a one-stop shop for compliance, effortlessly guiding employers from confusion to peace of mind.

Renalogic pioneered efforts to control CKD and ESRD’s financial and human costs in 2022 and has expanded such efforts over the last two decades. Today, the company’s services include ImpactIQ (a population health risk stratification analytics platform), ImpactCare (a patient education, care coordination, and health coaching service for members with early-stage CKD), ImpactAdvocate (an administrative and clinical support service for members with late-stage CKD and ESRD) and ImpactProtect (a cost containment service designed to help manage the financial burden of dialysis).

Together the companies serve more than 4,000 self-funded health plans, representing more than 750,000 lives in all 50 states and all sizes from 50 to 50,000 lives.

For more information about MZQ Consulting, visit

About Renalogic

Founded in 2002, Renalogic helps self-funded plans of all sizes and their U.S-based health plan members reduce the human and financial costs of chronic kidney disease (CKD) and dialysis treatment. We help plans manage dialysis claims costs and work to prevent members from progressing to dialysis. Through our cost containment and population health management solutions, Renalogic is 230% better than commercial plans at identifying undiagnosed CKD, 86% effective at preventing members from kidney failure and delivers 84.5% average savings off contracted rates with our claims repricing. We’ve saved our clients over $780,000,000 and helped stop CKD from progressing for thousands of members.